104 related articles for article (PubMed ID: 20870659)
1. Inter- and intraobserver variation in the histopathological evaluation of early oesophageal adenocarcinoma.
Grotenhuis BA; van Heijl M; ten Kate FJ; Biermann K; Offerhaus GJ; Wijnhoven BP; van Berge Henegouwen MI; Tilanus HW; van Lanschot JJ
J Clin Pathol; 2010 Nov; 63(11):978-81. PubMed ID: 20870659
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors.
Barbour AP; Jones M; Brown I; Gotley DC; Martin I; Thomas J; Clouston A; Smithers BM
Ann Surg Oncol; 2010 Sep; 17(9):2494-502. PubMed ID: 20349213
[TBL] [Abstract][Full Text] [Related]
3. Obesity is not associated with adverse outcome following surgical resection of oesophageal adenocarcinoma.
Madani K; Zhao R; Lim HJ; Casson SM; Casson AG
Eur J Cardiothorac Surg; 2010 Nov; 38(5):604-8. PubMed ID: 20444616
[TBL] [Abstract][Full Text] [Related]
4. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
7. Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus.
Metzger R; Drebber U; Baldus SE; Mönig SP; Hölscher AH; Bollschweiler E
Ann Surg Oncol; 2009 Feb; 16(2):447-53. PubMed ID: 19037700
[TBL] [Abstract][Full Text] [Related]
8. The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy?
Courrech Staal EF; Wouters MW; van Sandick JW; Takkenberg MM; Smit VT; Junggeburt JM; Spitzer-Naaykens JM; Karsten T; Hartgrink HH; Mesker WE; Tollenaar RA
Eur J Cancer; 2010 Mar; 46(4):720-8. PubMed ID: 20044247
[TBL] [Abstract][Full Text] [Related]
9. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
[TBL] [Abstract][Full Text] [Related]
10. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction.
de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C
Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study.
Madani K; Zhao R; Lim HJ; Casson AG
Eur J Cardiothorac Surg; 2010 Jun; 37(6):1427-32. PubMed ID: 20227286
[TBL] [Abstract][Full Text] [Related]
12. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.
Abraham SC; Krasinskas AM; Correa AM; Hofstetter WL; Ajani JA; Swisher SG; Wu TT
Am J Surg Pathol; 2007 Nov; 31(11):1719-25. PubMed ID: 18059229
[TBL] [Abstract][Full Text] [Related]
13. [Surgical therapy of esophageal cancer--early results].
Hildebrandt J; Nürnberger H; Lehner J; Löhlein D
Med Klin (Munich); 1994 Sep; 89(9):459-63. PubMed ID: 7968879
[TBL] [Abstract][Full Text] [Related]
14. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
Lewis JT; Wang KK; Abraham SC
Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
16. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma.
Brundler MA; Harrison JA; de Saussure B; de Perrot M; Pepper MS
J Clin Pathol; 2006 Feb; 59(2):191-5. PubMed ID: 16443737
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies.
Courrech Staal EF; Smit VT; van Velthuysen ML; Spitzer-Naaykens JM; Wouters MW; Mesker WE; Tollenaar RA; van Sandick JW
Eur J Cancer; 2011 Feb; 47(3):375-82. PubMed ID: 21036599
[TBL] [Abstract][Full Text] [Related]
19. Current strategy in surgery for esophageal cancer.
Siewert JR; Hölscher AH
Ann Ital Chir; 1992; 63(1):13-8. PubMed ID: 1605440
[TBL] [Abstract][Full Text] [Related]
20. Vascular invasion is not a risk factor in oesophageal cancer recurrence.
Waraich N; Rashid F; Jan A; Semararo D; Deb R; Leeder PC; Iftikhar SY
Int J Surg; 2011; 9(3):237-40. PubMed ID: 21167325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
